Gastric acid suppression (ASs) impact on the effectiveness of tyrosin kinase inhibitors (TKIs) in patients (p) with non-small-cell lung carcinoma (NSCLC).
2016 ◽
Vol 34
(15_suppl)
◽
pp. e20641-e20641
2011 ◽
Vol 2011
◽
pp. 69-70
2014 ◽
Vol 14
(1)
◽
pp. 97-110
◽
2010 ◽
Vol 133
(6)
◽
pp. 922-934
◽